FREE SHIPPING on your order, Orders $25 and Up! Use Code: CAPABLE - Exclusions Apply
Click to Order By Phone

More Views

Pregestimil DHA & ARA Infant Formula

By Mead Johnson

Availability: In stock

Pregestimil is an Infant Formula designed for babies having trouble absorbing fat. Pregestimil contains MCT oil that is more easily absorbed by infants.
Fast Shipping! Secure Shopping Easy Returns
Item# Description Size Price
036721

Unflavored, Powder 1 Pound Can

Each

Regular Price: $58.02

Sale Price: $43.94

036721

Unflavored, Powder 1 Pound Can

Case of 6

Regular Price: $348.14

Sale Price: $242.70

Description

Details

Pregestimil is an Infant Formula designed for babies having trouble absorbing fat. Pregestimil contains MCT oil that is more easily absorbed by infants. Manufactured by Mead Johnson, Pregestimil Formula for Infants helps infants with GI problems. Pregestimil DHA & ARA Infant Formula is lactose-free and hypoallergenic. Mead Johnson adds DHA and ARA nutrients to Pregestimil to help to promote brain and eye development.

Pregestimil DHA & ARA Infant Formula Features & Benefits

  • Formulated for babies with fat malabsorption.
  • Pregestimil® is an infant formula with 55% of the fat from medium-chain triglycerides.
  • Includes LIPIL, a blend of DHA and ARA nutrients found in breast milk.
  • Promotes brain and eye development.

Pregestimil Infant Formula Specifications

  • Pregestimil Infant Formula Product Numbers: 143301, 036721.
  • Size Options: 1 Pound or 2 Ounce.
  • Container Types: Can or Bottle.
  • Flavor: Unflavored Milk.
  • Application: Infant Formula for Infants with Gastrointestinal Problems.
  • Preparation: Powder or Ready-to-Use.
  • DHA: 17 mg.
  • ARA: 34 mg.
  • Iron fortified.
  • MCT Oil.
  • Lactose-free.
  • Sucrose-free.
  • Hypoallergenic.
  • Virtually Isotonic.
  • Users: Infants.
  • Manufacturer: Mead Johnson.
  • Brand: Pregestimil.
  • Shipping Weight: 7.3 lbs.
  • UNSPSC Code: 42231802.
  • HCPCS Code: B4161.

Pregestimil DHA & ARA Infant Formula Ingredients

Powder 1 Pound Can: Corn Syrup Solids (42%), Casein Hydrolysate* (from Milk) (16%), Medium Chain Triglycerides (MCT Oil) (15%), Modified Corn Starch (7%), Corn Oil (2%), High Oleic Vegetable Oil (Safflower Or Sunflower) (2%), And Less Than 2%: Mortierella Alpina Oil**, Crypthecodinium Cohnii Oil+, Vitamin A Palmitate, Vitamin D3, Vitamin E Acetate, Vitamin K1, Thiamin Hydrochloride, Riboflavin, Vitamin B6 Hydrochloride, Vitamin B12, Niacinamide, Folic Acid, Calcium Pantothenate, Biotin, Ascorbic Acid, Choline Chloride, Inositol, Calcium Citrate, Calcium Phosphate, Magnesium Oxide, Ferrous Sulfate, Zinc Sulfate, Manganese Sulfate, Cupric Sulfate, Sodium Iodide, Sodium Citrate, Potassium Citrate, Potassium Chloride, Potassium Hydroxide, Sodium Selenite, L-Cystine, L-Tyrosine, L-Tryptophan, Taurine, L-Carnitine. *Modified to Be Better Tolerated In Milk Allergic Babies, **A Source of Arachidonic Acid (Ara), +A Source of Docosahexaenoic Acid (DHA).

Ready-to-use 20 Calories 2 Fluid Ounce Bottle: Water (87%), corn syrup solids (5%), casein hydrolysate (from milk)§ (2%), medium-chain triglycerides (MCT oil) (2%) and less than 2%: modified corn starch, soy oil, high oleic vegetable oil (safflower and/or sunflower oils), Mortierella alpina oil, Crypthecodinium cohnii oil, carrageenan, vitamin A palmitate, vitamin D3, vitamin E acetate, vitamin K1, thiamin hydrochloride, riboflavin, vitamin B6 hydrochloride, vitamin B12, niacinamide, folic acid, calcium pantothenate, biotin, ascorbic acid, choline chloride, inositol, calcium carbonate, calcium hydroxide, calcium phosphate, potassium phosphate, magnesium chloride, ferrous sulfate, zinc sulfate, manganese sulfate, cupric sulfate, sodium citrate, sodium iodide, potassium citrate, sodium selenite, potassium chloride, L-cystine, L-tyrosine, L-tryptophan, taurine, L-carnitine.

Pregestimil Infant Formula Nutrition

Nutrient Values For Various Forms

Form

Cal

Pro

Fat

Carb

Cal

Pro

Fat

Carb

per 100 mL

per fl oz

Nursette Bottle - 20 Cal/fl oz

68

1.89 g

3.8 g

6.9 g

20

0.56 g

1.12 g

2 g

per 100 g

per scoop (8.9 g)

Powder

500

14 g

28 g

51 g

45

1.25 g

2.5 g

4.5 g

(Normal Dilution)

Per 100 Calories

Per 100 grams

20 Cal/fl oz RTU & Pwd (5 fl oz)

24 Cal/fl oz RTU (4.2 fl oz)

Powder (500 Cal)

Protein, g

2.8

2.8

14

Fat, g

5.6

5.6

28

Linoleic acid, mg

940

940

4700

Carbohydrate, g

10.2

10.2

51

Water, g

133 (RTU) 131 (Pwd)

108

2.6

(Normal Dilution)

Per 100 Calories

Per 100 grams

20 Cal/fl oz RTU & Pwd (5 fl oz)

24 Cal/fl oz RTU (4.2 fl oz)

Powder (500 Cal)

Vitamin/Other Nutrients

Vitamin A, IU

350

350

1750

Vitamin D, IU

50

50

250

Vitamin E, IU

4

4

20

Vitamin K, mcg

12

12

60

Thiamin (Vitamin B1), mcg

80

80

400

Riboflavin (Vitamin B2), mcg

90

90

450

Vitamin B6, mcg

60

60

300

Vitamin B12, mcg

0.3

0.3

1.5

Niacin, mcg

1000

1000

5000

Folic acid (Folacin), mcg

16

16

80

Pantothenic acid, mcg

500

500

2500

Biotin, mcg

3

3

15

Vitamin C (Ascorbic acid), mg

12

12

60

Choline, mg

24

24

120

Inositol, mg

17

17

85

(Normal Dilution)

Per 100 Calories

Per 100 grams

20 Cal/fl oz RTU & Pwd (5 fl oz)

24 Cal/fl oz RTU (4.2 fl oz)

Powder (500 Cal)

Minerals

Calcium, mg

94

94

470

Phosphorus, mg

52

52

260

Magnesium, mg

8

8

40

Iron, mg

1.8

1.8

9

Zinc, mg

1

1

5

Manganese, mcg

25

25

125

Copper, mcg

75

75

380

Iodine, mcg

15

15

75

Selenium, mcg

2.8

2.8

14

Sodium, mg

47

47

240

Potassium, mg

110

110

550

Chloride, mg

86

86

430

† Product nutrient values and ingredients are subject to change. Please see product label for current information.

Pregestimil Indications

Pregestimil is designed for infants who experience fat malabsorption and who may also be sensitive to intact proteins. Fat malabsorption or steatorrhea may be associated with cystic fibrosis, short bowel syndrome, intractable diarrhea and severe protein calorie malnutrition.

Long-Term Usage
Pregestimil is designed to provide a sole source of nutrition for infants up to age 6 months, and to provide a major source of nutrition through 12 months of age. Normally, in feeding infants, gradual introduction of solid foods after 4–6 months of age is an important developmental as well as nutritional step.

In cases of chronic malabsorption disorders, Pregestimil is sometimes continued as a milk substitute in the diet of children. This and similar supplemental use of Pregestimil in the diet beyond 12 months of age may make a significant contribution to the maintenance of good nutrition in such patients, and is not known to be harmful in any way. When Pregestimil is used as a milk substitute, the total calcium content of the diet should be assessed.

Extended use of Pregestimil (or other infant formulas) as a sole source of diet is most appropriately monitored by physicians and nutritionists on a case-by-case basis, with attention to developmental as well as nutritional implications of such a dietary regimen.

Pregestimil Additional Information

  • Birch EE, Hoffman DR, Uauy R, et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209.
  • Birch EE, Garfield S, Hoffman DR, et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.
  • Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr. 2002;75:570-580.
  • Hoffman DR, Birch EE, Castañeda YS, et al. Maturation of visual and mental function in 18-month old infants receiving dietary long-chain polyunsaturated fatty acids (LCPUFAs) [abstract]. FASEB J. 2003;17:A727-A728. Abstract 445.1.
  • Hoffman DR, Birch EE, Castañeda YS, et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142:669-677.
  • Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.
  • Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871-879.
  • Morale SE, Hoffman DR, Castañeda YS, et al. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197-203.
  • Fomon SJ, Ziegler EE. Renal solute and potential renal solute load in infancy. J Pediatr. 1999;134:11-14.
  • Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982;36:950-962.
  • Innis SM. Human milk and formula fatty acids. J Pediatr. 1992;120(suppl): S56-S61.
  • Koletzko B, Thiel I, Abiodun PO. The fatty acid composition of human milk in Europe and Africa. J Pediatr. 1992;120(suppl):S62-S70.
  • Jensen RG. Lipids in human milk. Lipids. 1999;34:1243-1271.
  • The British Nutrition Foundation. Recommendations for intakes of unsaturated fatty acids. In: Unsaturated Fatty Acids: Nutritional and Physiological Significance: The Report of the British Nutrition Foundation's Task Force. London: Chapman & Hall; 1992:152-163.
  • FAO/WHO Joint Expert Consultation. Lipids in early development. In: Fats and oils in human nutrition. Report of a joint expert consultation. Food and Agriculture Organization of the United Nations and the World Health Organization. FAO Food and Nutr Pap. 1994;57:49-55.
  • Simopoulos AP, Leaf A, Salem N Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr. 1999;18:487-489.
  • Koletzko B, Agostoni C, Carlson SE, et al. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr. 2001;90:460-464.
  • Ziegler EE, Fomon SJ. Methods in infant nutrition research: balance and growth studies. Acta Paediatr Scand Suppl. 1982;299:90-96.
  • Richardson GG, Leary L, Halsey JF. Allergenicity of corn-derived carbohydrate ingredients for use in infant formulas [abstract]. Presentation at American College of Allergists 5th International Food Allergy Symposium. October 15-18,1984.
  • Nutrient Requirements for Infant Formulas. Code of Federal Regulations 21, C.F.R. 107.100. April 1, 2006.
  • American Academy of Pediatrics, Committee on Nutrition. Iron fortification of infant formulas. Pediatrics. 1999;104:119-123.
  • Jirapinyo P, Young C, Srimaruta N, et al. High-fat semielemental diet in the treatment of protracted diarrhea of infancy. Pediatrics. 1990;86:902-908.
  • Cordano A, Gastanaduy AS, Graham GG. Absorption and retention from an iso-osmolal casein hydrolysate infant formula. Nutrition Research. 1988;8:1353-1362.
  • Kaufman SS, Scrivner DJ, Murray ND, et al. Influence of Portagen and Pregestimil on essential fatty acid status in infantile liver disease. Pediatrics. 1992;89:151-154.
  • Carlson SE, Mehra S, Kagey WJ, et al. Growth and development of term infants fed formulas with docosahexaenoic acid (DHA) from algal oil or fish oil and arachidonic acid (ARA) from fungal oil [abstract]. Pediatr Res. 1999;45:278A.
  • Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146:461-468.
  • Wheaton DH, Castañeda YS, Hoffman DR, et al. Biosafety of docosahexaenoic acid (DHA)/arachidonic acid (ARA) enriched infant formula fed for 9 months [abstract]. J Am Coll Nutr. 2003;22:469. Abstract 56.
  • U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition web site. Agency response letter GRAS Notice No. GRN 000041. Available at: http://www.cfsan.fda.gov/~rdb/opa-g041.html. Accessed April 19, 2007.
  • U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition web site. Agency response letter GRAS Notice No. GRN 000080. Available at: http://www.cfsan.fda.gov/~rdb/opa-g080.html. Accessed April 19, 2007.
  • Pregestimil has been clinically shown to be useful in the nutritional management of infants with fat malabsorption. A study of infants with severe diarrhea found that fat from Pregestimil was well absorbed. In addition, this study found that feeding Pregestimil promoted weight gain and improvements in anthropometric and biochemical measurements. Clinical studies also showed that Pregestimil promoted growth of infants with cystic fibrosis and infants recovering from malnutrition. In infants with chronic liver disease, Pregestimil promoted appropriate essential fatty acid status.
  • The sources of DHA and ARA in Pregestimil are well tolerated and safe. In clinical studies comparing infants fed formulas including LIPIL with infants fed formulas without LIPIL, there were no clinically significant differences in tolerance, and the addition of LIPIL had no effect on the incidence of adverse events. The sources of DHA and ARA in Pregestimil are Generally Recognized as Safe (GRAS) for use in infant formulas by the U.S. Food and Drug Administration.
Additional Information

Additional Information

Manufacturer Mead Johnson
Reviews
Community Q&A

Product Questions

No questions yet. Be the first to ask the question!

Product Reviews

Tell us what you think about this item!

Please, wait...